BLFS vs OXY · rev $56.0M vs rev $21.59B
BioLife Solutions Inc (BLFS) versus OXY (OXY) — a side-by-side from cached financials, not a winner call.
BioLife Solutions Inc (BLFS) is a medical instruments & supplies company listed on US.
OXY (OXY) common stock.
Latest reported BLFS revenue for 2026-06-30 was $56.0M. Net income was $46.3M. BLFS currently screens at market cap $1.05B.
Latest reported OXY revenue for 2025-12-31 was $21.59B. Net income was $2.37B. Revenue was down 19.2% from 2024-12-31 to 2025-12-31. OXY currently screens at market cap $0.
BLFS currently screens at market cap $1.05B. OXY currently screens at market cap $0.
Not investment advice. Open the BLFS and OXY stock pages for the full models.
Not investment advice.